Skip to main content
OpenTrials
Completed

NCT Number: NCT05370170

Ottawa Nutritional Guidelines for Nausea and Vomiting

Effect of Implementing Ottawa Nutritional Guidelines on the Course of Nausea and Vomiting During Pregnancy (A Randomized Control Trial)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nausea Gravidarum

Age range

22 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Faculty of Nursing

Cairo, Egypt

About this study

Studying the Effect of Implementing Ottawa Nutritional Guidelines on the Course of Nausea and Vomiting During Pregnancy (A Randomized Control Trial) using no pharmacological agents and life style modification in addition to acupressure to treat nausea and vomiting of pregnancy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primigravida
  • gestational age of 7-13 weeks
  • singleton pregnancy
  • having a score of 7-12 on the (PUQE 24)
  • can read and write
  • having phone number
  • not receiving medications for reducing NVP, except for vitamin B6
  • wanted pregnancy.

Exclusion criteria

  • subject's unwillingness to continue the study
  • occurrence of obstetric complications during the study
  • hyper-emesis gravidarum
  • having physical or mental disorders
  • having oral/speech impairments
  • having assisted reproductive techniques for the present pregnancy
  • having two consecutive miscarriages before the current pregnancy
  • old primigravida
  • narcotic use or alcohol drinking
  • and subjects who will show signs and symptoms of hyperemesis gravidarum during the study will be dropped out and referred to medical care.

Treatment and study plan

Acupressure and nutritional advices

Behavioral

Teaching using booklets and application of acupressure

Primary outcomes

  1. control nausea and vomiting

    Time frame: 3 weeks

    control the frequency and severity of nausea and vomiting and measure it by using Pregnancy Unique Quantification of Emesis

Secondary outcomes

  1. maintain normal body weight and prevent hospitalization

    Time frame: 3 weeks

    Monitor mother weight by calipered weight scale to monitor weight loss related to nausea and vomiting

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Effect of Implementing Ottawa Nutritional Guidelines on the Course of Nausea and Vomiting During Pregnancy (A Randomized Control Trial)

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
May 11, 2022
Registry last updated
Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.